Classification of Philadelphia Translocation-Negative Myeloproliferative Neoplasms: Its Impact on Data From Clinical Trials Reply

Classification of Philadelphia Translocation-Negative Myeloproliferative Neoplasms: Its Impact on Data From Clinical Trials Reply

Detalles Bibliográficos
Main Authors:	Campbell, P, Bareford, D, Erber, W, Wilkins, B, Wright, P, Buck, G, Wheatley, K, Harrison, C, Green, A
Formato:	Journal article
Publicado:	2009

Títulos similares

Philadelphia-negative chronic myeloproliferative neoplasms
por: Rosane Isabel Bittencourt, et al.
Publicado: (2012-01-01)

Molecular biology of Philadelphia-negative myeloproliferative neoplasms
por: Paulo Vidal Campregher, et al.
Publicado: (2012-01-01)

Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms
por: Basel Elsayed, et al.
Publicado: (2023-03-01)

JAK2-positive Philadelphia-negative myeloproliferative neoplasms
por: Anjali Sharma, et al.
Publicado: (2011-01-01)

Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
por: Yonal-Hindilerden Ipek, et al.
Publicado: (2017-03-01)

Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al
por: Campbell, P, et al.
Publicado: (2009)

The Prognostic Role of Cytogenetics Analysis in Philadelphia Negative Myeloproliferative Neoplasms
por: Giuseppe Lanzarone, et al.
Publicado: (2021-08-01)

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
por: Maira da Costa Cacemiro, et al.
Publicado: (2018-04-01)

Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
por: Jason B. Kaplan, et al.
Publicado: (2016-01-01)

Pediatric Philadelphia-Negative Myeloproliferative Neoplasms in the Era of WHO Classification: A Systematic Review
por: Abdulrahman F. Al-Mashdali, et al.
Publicado: (2023-01-01)

Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms
por: Chiara Elena, et al.
Publicado: (2011-08-01)

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
por: Beer, P, et al.
Publicado: (2008)

PB2054: HIP AND KNEE OSTEOARTHRITIS IN PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
por: H. Holik, et al.
Publicado: (2022-06-01)

P1020: SCREENING FOR PORTAL HYPERTENSION IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
por: M. Davidson, et al.
Publicado: (2022-06-01)

The Approach to Thrombosis Prevention across the Spectrum of Philadelphia-Negative Classic Myeloproliferative Neoplasms
por: Steffen Koschmieder
Publicado: (2021-06-01)

Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms
por: Cristina Pérez, et al.
Publicado: (2013-09-01)

Protein disulfide isomerase in Philadelphia-negative myeloproliferative neoplasms: a case–control study
por: Marwa Salah Mohammed, et al.
Publicado: (2025-02-01)

Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review
por: Samuel Bogdan Todor, et al.
Publicado: (2024-08-01)

TRANSCRIPTOMIC PROFILING SUGGESTS DYSREGULATED ACTIVATION OF B AND T LYMPHOCYTES IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
por: VL Bassan, et al.
Publicado: (2024-10-01)

Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms
por: Jenny Dahlström, et al.
Publicado: (2015-10-01)

Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms
por: Mattia Schino, et al.
Publicado: (2020-11-01)

SECONDARY SOLID CANCER FREQUENCY AND RISK FACTORS IN PHILADELPHIA- NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS
por: Fehmi Hindilerden, et al.
Publicado: (2024-05-01)

Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in , and
por: Yan Wang MM, et al.
Publicado: (2023-02-01)

THE OUTCOME OF FATHERHOOD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, A SINGLE INSTITUTION EXPERIENCE
por: Elrazi Ali, et al.
Publicado: (2021-11-01)

Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
por: Juçara Gastaldi Cominal, et al.
Publicado: (2021-05-01)

Platelet indices in Philadelphia-negative chronic myeloproliferative neoplasms / Indicii plachetari de volum în neoplasmele mieloproliferative cronice Philadelphia-negative
por: Olteanu Ariela-Ligia, et al.
Publicado: (2015-06-01)

Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study
por: Fehmi Hindilerden, et al.
Publicado: (2024-12-01)

Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest
por: Julie Mondet, et al.
Publicado: (2015-01-01)

PB2212: ABDOMINAL AORTIC CALCIFICATION IN PATIENTS NEWLY DIAGNOSED WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASM
por: Myung-Won Lee, et al.
Publicado: (2023-08-01)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hans C. Hasselbalch, et al.
Publicado: (2021-12-01)

Clinical Characteristics and Prognostic Risks of Philadelphia-Negative Myeloproliferative Neoplasms at Cipto Mangunkusumo General Hospital
por: Sukrisman L
Publicado: (2022-09-01)

Thrombin generation - a potentially useful biomarker of thrombotic risk in Philadelphia-negative myeloproliferative neoplasms
por: Romeo-Gabriel Mihaila
Publicado: (2017-03-01)

Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
por: Ik-Chan Song, et al.
Publicado: (2021-09-01)

IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis
por: Cosimo Cumbo, et al.
Publicado: (2021-12-01)

Classification and personalized prognosis in myeloproliferative neoplasms
por: Grinfeld, J, et al.
Publicado: (2018)

Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.
por: Campbell, P, et al.
Publicado: (2009)

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
por: İpek Yonal Hindilerden, et al.
Publicado: (2023-08-01)

Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark
por: Brochmann N, et al.
Publicado: (2018-12-01)

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
por: Tarinee Rungjirajittranon, et al.
Publicado: (2019-02-01)

ISCHEMIC STROKE IN PATIENTS WITH PHILADELPHIA-NEGATIVE CLASSICAL MYELOPROLIFERATIVE NEOPLASMS: EPIDEMIOLOGY AND RISK FACTORS IN A SINGLE CENTER INSTITUTION
por: M.R. Ruiz, et al.
Publicado: (2020-11-01)